Cystic fibrosis transmembrane conductance regulator is involved in polyphenol-induced swelling of the endothelial glycocalyx  by Peters, Wladimir et al.
BASIC SCIENCE
Nanomedicine: Nanotechnology, Biology, and Medicine
11 (2015) 1521–1530Original Article
Cystic fibrosis transmembrane conductance regulator is involved in
polyphenol-induced swelling of the endothelial glycocalyx
Wladimir Peters, PhD, Kristina Kusche-Vihrog, PhD,
Hans Oberleithner, MD, Hermann Schillers, PhD⁎
Institute of Physiology II, University of Münster, Münster, Germany
Received 19 December 2014; accepted 23 March 2015
nanomedjournal.comAbstract
Previous studies show that polyphenol-rich compounds can induce a swelling of the endothelial glycocalyx (eGC). Our goal was to reveal
the mechanism behind the eGC-swelling. As polyphenols are potent modulators of fibrosis transmembrane conductance regulator (CFTR)
Cl− channel, the hypothesis was tested whether polyphenol-induced increase in CFTR activity is responsible for the eGC-swelling. The
impact of the polyphenols resveratrol, (−)-epicatechin, and quercetin on nanomechanics of living endothelial GM7373 cells was monitored
by AFM-nanoindentation. The tested polyphenols lead to eGC-swelling with a simultaneous decrease in cortical stiffness. EGC-swelling, but
not the change in cortical stiffness, was prevented by the inhibition of CFTR. Polyphenol-induced eGC-swelling could be mimicked by
cytochalasin D, an actin-depolymerizing agent. Thus, in the vascular endothelium, polyphenols induce eGC-swelling by softening cortical
actin and activating CFTR. Our findings imply that CFTR plays an important role in the maintenance of vascular homeostasis and may
explain the vasoprotective properties of polyphenols.
From the Clinical Editor: Many vascular problems clinically can be attributed to a dysregulation of endothelial glycocalyx (eGC). The
underlying mechanism however remains unclear. In this article, the authors used nanoindentation and showed that polyphenols could swell the
endothelial glycocalyx and alter its function. This investigative method can lead to further mechanistic studies of other molecular pathways.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
Key words: Resveratrol; Quercetin; Epicatechin; Cortical actin; Atomic force microscopy; Cell cortexThe luminal side of the endothelial cells is lined by a viscous
liquid surface layer, rich in carbohydrates, the endothelial
glycocalyx (eGC). The prominent constituents of the eGC are
the proteoglycans, formed by a core protein and one or more
attached carbohydrate side chains (glycosaminoglycans; GAGs).
Most commonlyGAG side chains are composed of heparan sulfate
(50-90%), the rest is formed by hyaluronic acid and chondroitin,
dermatan, and keratin sulfates.1 Some types of core proteins areConflicts of interest: None.
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licenses/by-nc-nd/4.0/).firmly attached to the cell surface (glypicans through a
glycosylphosphatidylinositol anchor and syndecans are transmem-
brane core proteins), whereas other proteoglycans, such as
decorins, versicans, perlecans, biglycans, and mimecans, were
secreted. The eGC is not a static structure but, under physiological
conditions, in a dynamic equilibrium. Enzymatic degradation,
shear-induced shedding, variable surface expression and biosyn-
thesis of proteoglycans/glycoproteins as well as variations in GAG
side chain sulfation lead to ongoing changes in the composition,
thickness and functional properties of the eGC.1,2 The proteogly-
cans togetherwith plasma proteins, lipids, and ions form a dynamic
and complex interface between blood and tissue with specific
functions, mainly the protection of the endothelium and the
regulation of vascular permeability.3 The eGC binds oxygen-
scavenging enzymes like the extracellular superoxide dismutase,
reducing oxidative stress and preventing endothelial dysfunction.1
The eGC controls the cell surface microenvironment, thus
representing a regulatory domain for biochemical processes on
the cell surface.1 It acts as a molecular sieve and a sensor of fluid
shear stress.1,4,5 Furthermore, eGC affects blood rheology by
reducing flow resistance due to its negative charge. The eGC formsonductance regulator is involved in polyphenol-induced swelling of the
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with a negatively charged glycocalyx,6 mitigating the wall shear
stress.7 Under physiological conditions adhesion molecules
(VCAMs, ICAMs and PECAM) are concealed by the eGC
preventing the attachment of leukocytes to the blood vessel wall.8,9
Due to the broad spectrum of functions, it is obvious that an
intact eGC is a prerequisite for a healthy vasculature. Damage of
the eGC can lead to vascular dysfunction like edema formation,
high blood pressure, accelerated inflammation, atherosclerosis,
platelet aggregation, hypercoagulability and loss of vascular
responsiveness.2,10-15 Thus, an understanding of eGC function
and regulation is essential for the prevention and treatment of
these vasculopathies.
Recently, it was shown thatWS 1442, an ethanolic extract from
Crataegus spp. induces an increase in the eGC volume and a
decrease in eGC stiffness, a process called “eGC swelling”. The
eGC swelling is accompanied by an alteration of eGC function.16
Since the understanding of eGC regulation could be the key for an
appropriate treatment of different vasculopathies, the present study
aims to disclose the mechanisms behind the WS 1442-induced
eGC swelling. WS 1442 is rich in polyphenols, which are
known for their vasoprotective effects.17,18 Some polyphenols
(e.g. quercetin, resveratrol) are capable of activating the cystic
fibrosis transmembrane conductance regulator (CFTR).19-22 In
airway epithelia, CFTR regulates, among others, the height of the
PCL (periciliary layer) by maintaining the ion and water
homeostasis. This keeps the glycocalyx highly hydrated and
preserves the low viscosity of the PCL.23 CFTR is not only a
chloride channel, but also a transporter of bicarbonate (HCO3
−).24
Before secretion, proteoglycans (constituents of the glycocalyx,
andmucins) are highly ordered in vesicles at high calcium and low
pH. After release, calcium is removed and pH increased due to
bicarbonate, thus allowing the polymeric proteoglycans to expand
to their highly hydrated gel-like structure.25 Therefore, HCO3
−
transport, and hence CFTR are suspected to play a key role in the
epithelial glycocalyx formation. However, there is evidence that
CFTR is not only expressed in epithelia, but has been described
also in the vascular endothelium.26-28
In this work, we tested the hypothesis that polyphenols act on
eGC through the activation of CFTR. We tested (i) the impact of
resveratrol, (−)-epicatechin and quercetin on the eGC stiffness
k(eGC) and height dx(eGC) and (ii) the role of CFTR in
polyphenol-induced eGC swelling, using CFTR inhibitors. By
applying nanoindentation methods we found that polyphenols
soften the cortical actin web of endothelial cells paralleled by
CFTR activation and eGC swelling.Methods
Reagents
All chemicals were purchased from Sigma Aldrich (Steinheim,
Germany) unless stated otherwise.
Cell culture
For experiments, bovine aortic endothelial GM7373 cells
(DSMZ, Braunschweig, Germany) in the passages 6-20 wereused. The cells were cultured at 37 °C and 5% CO2 in minimal
essential medium (Invitrogen Corp., La Jolla, CA, USA)
supplemented with 20% fetal calf serum (FCS; PAA Clone,
Coelbe, Germany), 1% MEM vitamins (Invitrogen), 1% MEM
nonessential amino acids (Invitrogen) and 1% Pen-Strep solution
(10,000 U/ml penicillin, 10 μg/ml streptomycin; Invitrogen). As
positive control in Western blot and immunofluorescence
experiments, human bronchial epithelial 16HBE14o- cells were
used. The cells were cultured at 37 °C and 5% CO2 in minimal
essential medium with L-glutamine (PAA Clone) supplemented
with 10% FCS, 1% MEM nonessential amino acids (Invitrogen),
1% Pen-Strep solution (10,000 U/ml penicillin, 10 μg/ml
streptomycin; Invitrogen). For atomic force microscopy (AFM)
and immunofluorescence experiments, the cells were seeded on
Ø15 mm glass cover slips and used after forming a confluent
monolayer. For Western blot, the cells were cultured in
Ø100 mm culture dishes until confluence was reached.
Atomic force microscopy
The nanomechanical properties of the cells were studied by
force-indentationmeasurements as described previously.16 Briefly,
it could be shown that endothelial cells consist of different
functional layerswith distinguishable stiffness.We could show that
the endothelial glycocalyx is a very soft structure, thus deformation
of the eGC is mainly reflected by the first part of the force distance
curve. Enzymatic digestion of the glycocalyx constituents revealed
that the first part of a force distance curve is evoked by the eGC as
the length and slope of this part of the force distance curve were
reduced after enzymatic treatment.16,29,30 No changes in the second
part of the force distance curves could be observed.29 Additionally,
it could be shown that the slope of the first part of force distance
curve, obtained on endothelial cells, strongly correlates with the
amount of eGC-constituents.16,30 A MultiMode AFM (Bruker,
Karlsruhe, Germany) was used. The cells were indented with a soft
cantilever (spring constant = 11 pN/nm; Novascan, Ames, IA,
USA) equipped with a spherical polystyrene tip (Ø = 1 μm). The
whole study was performed with one individual cantilever. An
indentation velocity of 300 nm/s and a maximal loading force of
300 pN were applied. Force–indentation curves were obtained,
from which the stiffness k and thickness dx of different cellular
layers were derived (Figure 1). We used stiffness (Newton per
meter) instead of elasticity (Young's modulus) in order to avoid
using assumptions that are not applicable for glycocalyx. Even the
more sophisticated “brush model” developed by Sokolov and
coworkers31,32 is not applicable since the latter describes the
contribution of the pericellular brush (various membrane protru-
sions and corrugations like microvilli, microridges, filopodia and
glycocalyx) to cells' mechanics rather than the glycocalyx as such.
The analysis of the force–indentation curves was performed with
Punias software (Release 1.8; http://punias.voila.net/). Determina-
tion of the contact point was done by linear interpolation of the
non-contact region (baseline fit). The deviation of the curve from
this baseline fit was identified as contact point. Starting from the
contact point a linear fit was performed within the apparent linear
regime of the curve. The goodness of linear fits is displayed in
PUNIAS by showing the coefficient of determination R2 during fit
range determination in real-time. The algorithm allows delimiting
Figure 1. Nanoindentation of endothelial cells. Stiffness k and height dx of the endothelial glycocalyx (eGC) were measured by atomic force microscopy. Cells
were indented with a spherical tip (d = 1 μm) mounted on a soft cantilever (k = 11 pN/nm). From the force F, needed to fully indent the eGC, the stiffness can
be calculated as k = F/dx. By further indentation, the stiffness of the cortex can also be obtained.
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boundary condition was set to R2 N 0.8. AFMmeasurements were
performed in HEPES buffered solution (standard composition in
mM: 135 NaCl; 5 KCl; 1 MgCl2; 1 CaCl2; 10 HEPES
(N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid); pH 7.4
at 37 ° C), supplemented with 1% FCS. We tested the impact of
(−)-epicatechin, quercetin, and resveratrol on dx(eGC) and k(eGC).
The polyphenols were dissolved in dimethylsulfoxide (DMSO)
as a 1000-fold stock solution and diluted in HEPES buffered
saline (final concentration: 10 μg/ml polyphenol, 0.1% DMSO).
Pilot experiments have shown that polyphenol concentrations of
10 μg/ml show the maximal effect on the eGC for the respective
polyphenol (data not shown).
To test whether an active CFTR is a prerequisite for
polyphenol-induced eGC swelling, we blocked CFTR prior to the
polyphenol treatment of the cells either with 100 μM 5-nitro-2-
(3-phenylpropylamino)benzoic acid (NPPB) (EMD Biosciences,
Billerica, USA) or with 10 μM CFTRInh172 (EMD Biosciences).
To test the impact of actin depolymerization on the eGC, cells were
treated with cytochalasin D (50 nM). All experiments were
performed in a paired fashion. The cells were indented in the
region over the nucleus, to ensure that the cell topography remains
comparable between the different experiments.Immunostaining
GM7373 and 16HBE14o- cells as a positive control were fixed
for 10 minutes at 4 °C with 4% formaldehyde dissolved in
phosphate buffered saline (PBS). Thereafter, cells were washedthree times with PBS and the cell surface was blocked with
10% normal goat serum for 30 minutes. The primary antibody
(monoclonal mouse anti-CFTR antibody LS-C14758 (Biozol,
Eching, Germany)) in a dilution of 1:500 was added. After
incubation for 1 h at room temperature, samples were washed with
PBS. Thereafter, 4′,6-diamidino-2-phenylindole (DAPI, 1:50,000)
and the secondary antibody Alexa 488 goat anti-mouse antibody
(1:500, Dako, Hamburg, Germany) were added and an incubation
for 1 h at room temperature followed this procedure. After
washing, the cells were mounted with Dako mounting medium
(Dako, Glostrup, Denmark). Immunofluorescence was obtained
with a Leica TCS SP8 confocal microscope (Leica Microsystems,
Wetzlar, Germany) using a 63× oil immersion objective.Western blot
Themembrane proteins ofGM7373 and 16HBE14o- cells were
isolated with the ProteoExtract Transmembrane Protein Extraction
Kit (Merck, Darmstadt, Germany) using the supplied extraction
buffer A. The protein concentrations were measured colorimetri-
cally using the Pierce BCA protein assay (Fisher Scientific,
Schwerte, Germany). For the detection of the CFTR, 40 μg of the
total membrane proteins was separated via SDS PAGE (7.5%
acrylamide) and subsequently transferred onto a nitrocellulose
membrane using the Trans-Blot SD semi-dry transfer cell
(Bio-Rad, München, Germany). Non-specific binding sites were
blocked by an overnight incubation at 4 °C with 5% skim milk
powder (Roth, Karlsruhe, Germany), dissolved in Tris-buffered
saline/Tween (TBST; 10 mM, Tris HCl (pH 7.4), 1.5 mM NaCl,
Figure 2. Polyphenol-induced swelling of the eGC. The endothelial glycocalyx (eGC) of bovine aortic GM7373 cells shows after treatment with 10 μg/ml o
resveratrol (A), quercetin (B), or (−)-epicatechin (C) a decrease in stiffness k(eGC) and an increase in height dx(eGC) within a few minutes. On the left side, a
representative time–response curve is shown, on the right side data of 10 paired experiments (t = 10 minutes) are summarized (N = 10). ⁎P b 0.001 vs control
Lowess-smoothing with a weight function of 0.1 was performed to smooth out the noise in the time–response curves.
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antibody LS-C14758 (1:500) diluted in 5% skim milk powder
in TBST and incubated for 1 h at room temperature. This
antibody detects only the mature, fully glycosylated CFTR
protein, as a band in the range of 170 kDa. Afterwards, the
membrane was washed 3 times with TBST and the secondary
antibody, coupled to an anti-mouse horseradish peroxidase
(1:10,000; Dianova, Hamburg, Germany) was applied for 1 h at
room temperature. After washing the membrane three times
with TBST, the membrane was incubated with SuperSignal
West Pico chemiluminescent substrate (Fisher Scientific) andf
.the secondary antibody was detected using ChemiDoc XRS gel
documentation system (Bio-Rad).
Statistical analysis
Data are presented as means (±SD). The statistical analysis
was done with STATISTICA 9 (StatSoft, Tulsa, OK, USA). All
AFM experiments were done in a paired fashion. Data of k(eGC)
and dx(eGC) were normalized for each cell relative to respective
control values for better comparability between the different test
series. Every cell is represented by 40 force–indentation curves.
Figure 3. CFTR is present in endothelial cells. The presence of the cystic fibrosis transmembrane conductance regulator (CFTR) in bovine aortic GM7373 cells is
confirmed by both immunofluorescence staining (A) and Western blot (B). Human bronchial epithelial 16HBO14o- cells are used as a positive control.
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evaluations were done by Mann–Whitney U-test. For the
comparison of multiple groups Kruskal–Wallis ANOVA
followed by post-hoc-tests was used. Significance level was
assumed as P ≤ 0.05. For plotting of time–response curves,
Lowess-smoothing with weight function of 0.1 was performed
to smooth out noise fluctuations.Results
Polyphenols induce eGC swelling
Under control conditions, dx(eGC) of living GM7373 cells
was in the range of 36-691 nm (mean = 169 nm, ± 90 nm SD,
N = 30 cells), k(eGC) was in the range from 0.05 to 0.66 pN/nm
(mean = 0.23 pN/nm ± 0.10 pN/nm SD, N = 30), which
corresponds to a Young's modulus value in the range of
25-430 Pa (mean = 135 Pa ± 16 Pa). All three polyphenols
resveratrol, quercetin, and (−)-epicatechin were able to induce
eGC swelling within 5-10 minutes (Figure 2). After reaching the
new steady state, no further changes in dx(eGC) and k(eGC)
occurred during the observed time frame (~30 minutes).
Treatment of GM7373 cells with 10 μg/ml resveratrol (44 μM)
led to an increase of dx(eGC) by 45% and a decrease of k(eGC)
by 57% (Figure 2, A). 10 μg/ml of quercetin (33 μM) induced
an increase of dx(eGC) by 43% and a decrease of k(eGC) by
38% (Figure 2, B). An increase of dx(eGC) by 59% and a
decrease of k(eGC) by 44% (Figure 2, C) were induced by
10 μg/ml of (−)-epicatechin (34 μM).
CFTR is present in endothelial cells
The presence of CFTR in GM7373 cells was validated by
immunofluorescence and Western blot (Figure 3). Usingimmunostaining, we could show that CFTR is present in the
membrane of GM7373 cells (Figure 3, A left). Human epithelial
16HBE14o- cells, which served as the positive control, showed a
comparable amount and distribution of CFTR in the membrane
(Figure 3, B right). No CFTR signal was detected in negative
controls (GM7373 cells incubated with second antibody only;
data not shown).
Further, we were able to detect CFTR in GM7373 cells using
the Western blot method (Figure 3, B). In both GM7373 and
16HBE14o- cell lines, the used antibody detected a signal at
170 kDa, which represents the fully glycosylated mature CFTR.
Polyphenol-induced eGC swelling is prevented by
CFTR inhibition
We tested our hypothesis that polyphenol-induced swelling of
the eGC occurs due to CFTR activation, by blocking the channel
prior to polyphenol treatment. In the presence of the CFTR
blocker CFTRInh172 (10 μM) or of the Cl
−-channel blocker
NPPB (100 μM), neither k(eGC) nor dx(eGC) was changed after
polyphenol treatment (Figure 4).
Polyphenols induce eGC swelling through the reorganization of
cortical actin
The AFM “captures” not only the nanomechanical properties of
eGC, but also those of the underlying cell cortex (50-150 nm
beneath the plasmamembrane). Interestingly, a parallel softening of
both eGC and cortex could be observed. However, in contrast to the
polyphenol-induced eGC swelling, the decrease of k(cortex) could
not be prevented byNPPBor CFTRInh172, indicating that softening
of the cortex is either an (CFTR-)independent or a preceding
process. Nanomechanics of the cortex is mainly determined by the
cortical actin web.33 To test, whether softening of the cell cortex is
directly involved in eGC swelling or whether it is an independent
Figure 4. Functional CFTR is a prerequisite for polyphenol-induced eGC
swelling. No changes in endothelial glycocalyx (eGC) stiffness k(eGC) or
height dx(eGC) can be observed when the cystic fibrosis transmembrane
conductance regulator (CFTR) is blocked prior to polyphenol treatment by
the CFTR inhibitor NPPB (100 μM) or CFTRInh172 (10 μM). N = 2
(paired); ⁎P b 0.001 vs control.
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the cortical actin as described previously.34 Treatment of cells with
50 nM cytochalasin D led to a decrease of the k(cortex) by 30%
within 8 minutes. Simultaneously, k(eGC) decreased by 28% and
dx(eGC) increased by 39%. The observation that the effects of
polyphenols on eGC can bemimicked by low doses of cytochalasin
D (Figure 5, B) indicates a permissive role of the cortical actin web
in polyphenol-induced eGC swelling.Discussion
Polyphenols have experienced increasing scientific interest due
to their possible usability as therapeutic agents. The protective
effects of polyphenols on the cardiovascular system have already
been documented.35,36 So far it could be shown that polyphenols
reduce oxidative stress and enhance the release of nitric oxide (NO)
by activating the endothelial NO synthase (eNOS), a major
endothelial determinant of endothelial function/dysfunction.37
Furthermore, there is evidence that polyphenols can, to some
extent, compensate the harmful effects of arterial hypertension
such as cardiovascular remodeling and vascular dysfunction.38-40
In a rat model of hyperaldosteronism it was shown that
polyphenols prevent the enhanced release of microparticles,
macrovascular inflammation, oxidative stress, and microvascular
endothelial malfunction.41 Based on the present data, we assume
that at least some of the beneficial effects of polyphenols on the
cardiovascular system are mediated by eGC swelling.Little is known about the physiological relevance of eGC
swelling. Glycocalyx serves as a cushion for blood cells,
preventing the contact between them and reducing the mechanical
stress for erythrocytes during the passage through small
capillaries.42,43 It is conceivable that a thick and soft “cushion”
is better than a stiff and thin one. Furthermore, the dimensions of
the eGC (either collapsed or swollen) are supposed to significantly
determine blood flow9,44 and the propagation of shear forces
across the vessel wall45-48 indicating that eGC swelling has a
potentially important impact on hemodynamics and vascular tone.
The endothelial glycocalyx, a composite of membrane tethered
proteoglycans and bound plasma proteins, regulates vascular
permeability by establishing a colloid osmotic (or oncotic) gradient
between the intracapillary lumen and the interstitium.49 This
explains also the edema formation following glycocalyx damage.
Proteoglycan associated carbohydrate residues serve as attachment
points for albumin and other blood borne proteins.50-55 Gel
swelling is associated with an increase in mesh size, which is
defined as the average distance between nearest segments of
neighboring macromolecules.56 An increased mesh size of eGC
should lead to an increased binding capacity for proteins. Thus,
water permeability of the vessel wall may be under control of eGC
swelling. The eGCbinds not only proteins but also ions48,57 and an
impact of eGC swelling on this function was shown recently.16
Additionally, changes in the mesh size could alter the molecular
sieve function of the eGC and thus determine the accessibility of
leucocytes and platelets to plasma membrane receptors (PECAM,
VCAMs, ICAMs, selectins, integrins). Together, eGC dynamics
(swelling and collapsing) seems to be a regulatory mechanism that
participates in control of capillary transport, immune response and
blood rheology.
The data show that a functional CFTR is a prerequisite for the
eGC swelling. In airway epithelia, CFTR regulates, among
others, the height and viscosity of the periciliary layer (PCL).58
Both lead to a mechanical environment that allows unhindered
ciliary beating, which is crucial for the mucociliary clearance and
health of the respiratory system. The PCL is formed by
surface-tethered polysaccharides showing a certain similarity to
the GAG-brush of eGC. Hydration and expansion of PCL are
maintained by CFTR-dependent water movement and HCO3
−
secretion. In the current model, polymeric proteoglycans
(mucins) are densely packed and highly ordered in granules
due to high calcium and low pH. The exocytotic release of mucin
is followed by an exchange ofCa2+ withNa+ and an increase of pH
due to secretion of HCO3
− causing the expansion and hydration of
mucin.59-61 CFTR obviously plays a crucial role in forming the
functional structure and mechanical properties of polymeric
proteoglycans (mucins, glycocalyx).62 It is conceivable that the
mechanism of expansion and hydration ofmucins is comparable to
that of proteoglycans of the eGC. In this scenario CFTR activity
“injects” bicarbonate and chloride right into the glycocalyx, thus
causing the expansion of the eGC and potentially also of freshly
released soluble proteoglycans. Our data indicate that CFTR plays
a role as a regulator of nanomechanical properties of the glycocalyx
not only in the epithelium, but also in the vascular endothelium.
All three tested polyphenols – resveratrol, (−)-epicatechin, and
quercetin – are able to induce eGC swelling within 5-10 minutes.
In this process, the eGC “unfolds” (expands) by up to 60% and
Figure 5. eGC swelling is mediated by cortical actin reorganization. Resveratrol (10 μg/ml) induces a decrease in cortical stiffness k(cortex) by 25% within ten
minutes (A). When the cystic fibrosis transmembrane conductance regulator (CFTR) is blocked prior to resveratrol treatment either with 10 μMCFTRInh172 or
100 μMNPPB, the cortical softening still occurs. Cytochalasin D (50 nM) leads to a softening of the cellular cortex by 30%within 8 minutes, accompanied by a
decrease in k(eGC) by 28% and an increase in dx(eGC) by 39%, mimicking the effect of polyphenols on the endothelial glycocalyx (eGC) (B). N = 2 (paired);
⁎P b 0.001 vs control. Lowess-smoothing with a weight function of 0.1 was performed to smooth out the noise in the time–response curves.
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CFTR was functionally blocked by NPPB or CFTRInh172 prior to
polyphenol treatment. For artificial polyelectrolyte gels in aqueous
solutions it was already shown that changes in ion concentration
or pH could induce a transition from collapse to swelling of the gel
and vice versa.63-66 Analogous, it was shown that biogels like the
cytoplasm can undergo drastic volume changes in response to
changes in pH, osmolality and ion concentration.67 It is likely that
comparablemechanisms could be responsible for the swelling of the
eGC. As the eGC is a polyanionic gel, the increased concentration
of Cl− within the eGC should lead to an increase in electrostatic
repulsive forces and osmotic pressure and thus to swelling.
According to this model, cations should have the opposite effect
on the eGC and indeed, it was observed that elevated extracellular
concentration of Na+ leads to a deranged eGC in vitro.30
Additionally, conformational changes (swelling and collapse) of
red blood cell glycocalyx in response to changes in the electrolyte
concentration were already detected more than thirty years ago.68
Polyphenols not only swell the eGC but also decrease the
cortical stiffness of endothelial cells. An important determinant of
the cortical stiffness is the polymerization state of the cortical actin
web.34 Our present findings imply that polyphenols affect the
reorganization of the cortical actin, which turns out as a part of theeGC swellingmechanism. This was shown by depolymerization of
cortical actin by low doses of cytochalasin D, which induces a
swelling of eGC in the absence of polyphenols. However, we also
found that inhibition of CFTR prevents polyphenol-induced eGC
swelling, but not the softening of the cortex. Evidently,
depolymerization of cortical actin “as such” is not sufficient for
eGC swelling, i.e. a functional CFTR (HCO3
−/Cl− efflux), is
required. Generally, anion efflux leads to depolarization of the
electrical membrane potential. It was shown that endothelial cells
respond to depolarization with a decrease of stiffness.69 Shear
stress, resulting from blood flow, activates Cl−-selective ion
channels causing depolarization.70 Physiologically, flow-induced
depolarization softens the endothelial cell cortex, which in turn
increases NO production.34 CFTR is not known as a “force
sensor”, therefore another chloride channel may trigger cortical
actin depolymerization, which in turn activates CFTR. Actin
directly interacts with several membrane channel proteins (CFTR
among others) and influences their activities.71 In this context it has
been shown that acute treatment of mouse mammary adenocar-
cinoma cells with cytochalasin D activates CFTR as well as the
addition of actin to excised inside-out patches.72 As suggested by
the authors, short actin filaments may lead to an activation of
CFTR. Summing up, we propose a mechanism of polyphenol-
Figure 6. Proposed mechanism behind polyphenol-induced eGC swelling. The polyphenols activate the cystic fibrosis transmembrane conductance regulator
(CFTR) (step 1) which induce the formation of short actin filaments (step 2). As a consequence, the activity of CFTR increases further (step 3), leading to an
increased HCO3
−/Cl−-efflux (step 4). The change in the “local” ionic and pH nanoenvironment at the endothelial cell surface, the gel-like glycocalyx swells
(step 5). A swollen (i.e. unfolded) glycocalyx serves as a physiological barrier against unfavorable interactions of blood constituents with the endothelial
plasma membrane.
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leading to membrane potential depolarization, thus inducing
cortical actin depolymerization. Short actin filaments now activate
CFTR further, which results in eGC swelling through electrostatic,
osmotic and pH effects upon direct “injection” of chloride and
bicarbonate into the glycocalyx (Figure 6).
The meaning of CFTR within eGC dynamics is evident.
Therefore it can be assumed that a defective CFTR would lead to
severe endothelial/vascular disorders. Cystic fibrosis (CF) is a
severe autosomal-recessive genetic disorder in which mutations
in the CFTR gene lead to defective processing and expression of
the CFTR protein. The loss of CFTR function reduces epithelial
transport,73 causing dehydration of the PCL and, as a
consequence, leading to lung diseases, which are the primary
cause of morbidity and mortality in CF patients.74 There is
increasing evidence that loss of CFTR function affects the
endothelium. Brown et al showed that CFTR function is
important for the maintenance of the lung endothelial barrier
and that the loss of CFTR function promotes lung inflammation
by increasing endothelial permeability.28 CF is accompanied by
increased plasma levels of the eGC constituents, ICAM-1 and
E-selectin, indicating sustained shedding of the eGC.75 CF leads
also to enhanced platelet activation, which promotes lung
inflammation and injury.76,77 In summary, it is likely thatCFTR is important for proper endothelial function. Mutation of
CFTR affects eGC dynamics which could aggravate the clinical
symptoms of CF.
In conclusion, the polyphenols resveratrol, (−)-epicatechin
and quercetin swell the endothelial glycocalyx and thus alter the
nanomechanics of vascular endothelium. The physiological
mechanism that we propose behind polyphenol-induced eGC
swelling is as follows: Polyphenols activate CFTR, leading to
membrane potential depolarization which induces cortical actin
depolymerization. Short actin filaments increase CFTR activity
further, which results in eGC swelling through electrostatic,
osmotic and pH effects upon direct “injection” of chloride and
bicarbonate into the glycocalyx. In this way endothelial cell can
adjust their eGC properties through a sophisticated interplay
between ion channel activity and cortical actin web. These
observations open a new perspective for the understanding of the
eGC function and regulation.Acknowledgments
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